InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 07/10/2019 1:10:23 PM

Wednesday, July 10, 2019 1:10:23 PM

Post# of 3504
News: $MBRX Moleculin Files for New Patents for Annamycin After Receiving FDA Approval of Fast Track Designation

HOUSTON , July 10, 2019 /PRNewswire/ -- Moleculin Biotech, Inc. (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced it has filed new patents covering the pr...

Read the whole news Moleculin Files for New Patents for Annamycin After Receiving FDA Approval of Fast Track Designation
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MBRX News